The Science Behind the Headlines
This WEEKLY delves deeper into the season’s favorite virus. More specifically, we look at some high-profile efforts to transform the flu vaccine into the pandemic-crusher of the WHO’s (World Health Organization) dreams.
The free Biotech Primer WEEKLY explains the science behind today’s headlines. Delivered each Thursday directly to your inbox.
Happy Flu Season! A throbbing headache, fever, chills—if you’ve ever enjoyed a few days off courtesy of influenza, you’ve got good reason to embrace the simple flu shot. Every year, millions of us roll up our sleeves and take our medicine. This WEEKLY reviews the ABCs of the flu virus and what you need to know about the vaccine.
Biotech for Non-Scientists
MISSION IMPOSSIBLE: MEATLESS MEAT? Imagine biting into a juicy cheeseburger: the flavor, the texture, the smell. Now, imagine the cheeseburger meatless. Impossible? No. Impossible Foods, a Redwood City, CA-based company has used biotechnology to create a plant-based...
Pharma Finish Line: FDA Approval Last week, we focused on the final stage of clinical testing, Phase III trials, where drug developers assess the safety and efficacy of their drug in large patient groups. At the end of Phase III, drug developers face the moment of...